Hormonal status in protracted critical illness and in-hospital mortality

[1]  Mulugeta Gebregziabher,et al.  Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. , 2010, American journal of epidemiology.

[2]  R. Stevens,et al.  Hormonal status and ICU-acquired paresis in critically ill patients , 2010, Intensive Care Medicine.

[3]  R. Stevens,et al.  Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality* , 2009, Critical care medicine.

[4]  A. Combes,et al.  Gender impact on the outcomes of critically ill patients with nosocomial infections* , 2009, Critical care medicine.

[5]  O. Tanner.  Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .

[6]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[7]  M. Christ-Crain,et al.  Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. , 2008, European journal of endocrinology.

[8]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[9]  Patrick R. Norris,et al.  Estradiol is associated with mortality in critically ill trauma and surgical patients , 2008, Critical care medicine.

[10]  B. de Jonghe,et al.  Respiratory weakness is associated with limb weakness and delayed weaning in critical illness* , 2007, Critical care medicine.

[11]  J. Differding,et al.  THE INFLUENCE OF SEX HORMONES ON COAGULATION AND INFLAMMATION IN THE TRAUMA PATIENT , 2007, Shock.

[12]  B. de Jonghe,et al.  Critical illness neuromyopathy: from risk factors to prevention. , 2007, American journal of respiratory and critical care medicine.

[13]  G. Van den Berghe,et al.  The dynamic neuroendocrine response to critical illness. , 2006, Endocrinology and metabolism clinics of North America.

[14]  G. Van den Berghe,et al.  Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness. , 2006, Endocrinology and metabolism clinics of North America.

[15]  D. Annane,et al.  Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. , 2006, Journal of Clinical Endocrinology and Metabolism.

[16]  R. Barrow,et al.  Endogenous Anabolic Hormones and Hypermetabolism: Effect of Trauma and Gender Differences , 2005, Annals of surgery.

[17]  S. Ridley,et al.  Drugs in anaesthesia , 2003, Anaesthesia.

[18]  K. Dhatariya.  Is there a role for dehydroepiandrosterone replacement in the intensive care population? , 2003, Intensive Care Medicine.

[19]  P. Metnitz,et al.  Gender-related differences in intensive care: A multiple-center cohort study of therapeutic interventions and outcome in critically ill patients* , 2003, Critical care medicine.

[20]  S. Bornstein,et al.  Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: Diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol , 2003, Critical care medicine.

[21]  Isabelle Durand-Zaleski,et al.  Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.

[22]  D. Annane,et al.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.

[23]  G. Drummond,et al.  Endocrine measurements in survivors and non-survivors from critical illness , 2002, Intensive Care Medicine.

[24]  G. Höffken,et al.  Adrenocortical function and inflammatory response during sepsis. , 2002, Critical care medicine.

[25]  L. Thijs,et al.  Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? , 2002, Critical care.

[26]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[27]  D. Annane,et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. , 2000, JAMA.

[28]  G. Van den Berghe,et al.  Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues , 1997, Clinical endocrinology.

[29]  J. Holly,et al.  Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. , 1996, Critical care medicine.

[30]  M. Kaplan,et al.  Reduced tissue thyroid hormone levels in fatal illness. , 1993, Metabolism: clinical and experimental.

[31]  S. Lowry,et al.  Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. , 1992, The Journal of clinical endocrinology and metabolism.

[32]  D. Sgoutas,et al.  Reversible impairment of gonadotropin secretion in critical illness. Observations in postmenopausal women. , 1989, Archives of internal medicine.

[33]  F. Kaiser,et al.  Gonadotropin determinations and thyrotropin-releasing hormone and luteinizing hormone-releasing hormone testing in critically ill postmenopausal women with hypothyroxinemia. , 1985, The Journal of clinical endocrinology and metabolism.

[34]  R. Hamill,et al.  Transient hypogonadotropic hypogonadism caused by critical illness. , 1985, The Journal of clinical endocrinology and metabolism.

[35]  M. Bondanelli,et al.  Systemic illness , 2008, Pituitary.

[36]  I. Vanhorebeek,et al.  Endocrine aspects of acute and prolonged critical illness , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[37]  J. Chastre,et al.  Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN model , 2005, Intensive Care Medicine.

[38]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[39]  G. Van den Berghe,et al.  A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. , 2000, The Journal of clinical endocrinology and metabolism.

[40]  G. Van den Berghe,et al.  Increased mortality associated with growth hormone treatment in critically ill adults. , 2000, The New England journal of medicine.

[41]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.